End-stage kidney disease (ESKD) is an expensive condition to manage in contemporary health care for the healthcare provider, patient and family . People affected by ESKD usually require kidney replacement therapy in the form of dialysis or kidney transplantation to survive . Projections of the prevalence of those requiring treatment of ESKD will rise by 60%-from 19,780 cases in 2011 to 31,589 cases in 2020  in Australia.
|Number of pages||13|
|Publication status||Unpublished - 2019|